Learn more

QIAGEN GMBH

Overview
  • Total Patents
    1,414
  • GoodIP Patent Rank
    4,433
  • Filing trend
    ⇩ 68.0%
About

QIAGEN GMBH has a total of 1,414 patent applications. It decreased the IP activity by 68.0%. Its first patent ever was published in 1986. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology, chemical engineering and measurement are STRATAGENE CALIFORNIA, ZYMO RES CORP and TAKARA BIO USA INC.

Patent filings per year

Chart showing QIAGEN GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Himmelreich Ralf 108
#2 Loeffert Dirk 89
#3 Fabis Roland 84
#4 Korfhage Christian 78
#5 Fang Nan 72
#6 Sprenger-Haussels Markus 65
#7 Erbacher Christoph 62
#8 Engel Holger 57
#9 Voit Thomas 56
#10 Rothmann Thomas 55

Latest patents

Publication Filing date Title
WO2021058692A1 Multimodal analysis of stabilized cell-containing bodily fluid samples
WO2021032583A1 Composition and method for amplification of str loci
WO2020260618A1 Method for separating nucleic acid molecules by size
WO2020260620A1 Method for enriching nucleic acids by size
WO2020193368A1 Method for improving the amplification efficiency of bead-based emulsion pcr (empcr)
WO2020141187A1 Urine stabilization
WO2020141144A1 Enrichment method for sequencing
EP3733869A1 Automated method and system for split pool based barcoding of cellular molecules
WO2019243352A1 Method for improving data quality of biological samples in a semi-automated processing environment
JP2019136044A Stabilization and isolation of extracellular nucleic acids
CN112004927A Method for isolating nucleic acids from plant samples
AU2019258956A1 Method for isolating nucleic acids from plant samples
CN112055748A Method for lysing plant sample
EP3702474A1 Sequencing method and kit
EP3699297A1 A method for determining the level of an antisense oligonucleotide
US2021078003A1 Sequencing flowcells
US2019309343A1 Stabilisation and isolation of extracellular nucleic acids
WO2019011875A1 QUANTIFICATION OF ANTI SENSE OLIGONUCLEOTIDES (ASOs)
EP3642746A1 Method and apparatus for performing a normalization in the context of sequencing analysis
US2020010906A1 Method for analyzing the expression of one or more biomarker rna molecules